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Case presentation
A 52-year-old woman was scheduled for modified radical 
mastectomy on account of  advanced carcinoma of  the right 
breast. The patient was a known hypertensive and diabetic, 
diagnosed 3 years prior to presentation and also a known 
asthmatic, diagnosed at childhood. She was being managed 
with lisinopril, amlodipine, and Mixtard insulin injection. 
However, she was not compliant on her medications. Three 
days before the scheduled surgery, her blood pressure (BP) 
was 170/110 mmHg, and fasting blood sugar was 10.8 
mmol/L. Additionally, she suffered an asthmatic attack 2 days 
prior to surgery. Her regular doses of  antihypertensive drugs 
and insulin(42 IU/day) were increased, while salbutamol 
inhaler at 2 puffs as required, along with aminophylline and 
prednisolone tablets were used to manage the mild asthmatic 
attack. 
On the evening prior to surgery her vital signs were as follows: 
pulse rate (PR) 88/minute, BP 130/70 mmHg, respiratory 
rate (RR) 20/minute and temperature 36.8°C. Her chest was 
clinically clear and other examination findings were normal. 
Her packed cell volume (PCV) was 36%. Electrocardiogram 
(ECG) and chest x-ray findings were suggestive of  left 
ventricular hypertrophy. Other investigation results, 
including electrolyte, urea, and creatinine were within normal 
limits. Based on the comorbid conditions, she was assigned 
class to III of  the American Society of  Anesthesiologists 
(ASA) classification scheme. She was counselled for thoracic 
epidural anaesthesia, as general anaesthesia was considered 
a more risky alternative, and consent for the procedure was 
obtained. 
On the morning of  surgery her fasting blood sugar was 8.9 
mmol/L and 500 mL of  5% dextrose water infusion, into 
which 5 mmol of  potassium and 5 IU of  soluble insulin were 
added, was set up to run at 100 mL/hour. Additionally, the 
morning doses of  her regular antihypertensive medications 
were  given.
In theatre, a multiparameter monitor was attached to the 
patient, measuring peripheral capillary oxygen saturation 
and noninvasive BP. Baseline values were as follows: PR 84/
minute, BP 110/70 mmHg, and SpO2 96%. In the sitting 
position, a midline thoracic epidural was performed at the 
T4/T5 interspinous space using a size 18G Tuohy epidural 
needle and loss of  resistance to air technique. The skin 
epidural depth was 5 cm, and 4 cm of  the epidural catheter 
was left in situ in the epidural space in the cephalad direction, 
and the catheter adhered to the back with adhesive tape. 
After a test dose of  3 mL of  1% lidocaine with adrenaline, 
a loading dose of  7 mL of  2% lidocaine with adrenaline 
1:200,000 was given in 4 mL and 3 mL aliquots at 5-minute 
intervals. The epidural catheter was connected to a syringe 
pump for continuous infusion of  2% lidocaine–adrenaline 
at 4 mL/hour. 
Five minutes later, a sensory block height of  T1 to T10 was 
achieved bilaterally, and the surgery commenced. The breast 
tissues and tumour were excised en bloc, including fibrofatty 
tissues of  the medial aspect of  the right axilla. Oxygen was 
given via face mask at 4 L/minute throughout the duration 
of  the surgery, which lasted for 2 hours, 40 minutes. No 
sedation was used.
The estimated blood loss was 1.2 L; 1 unit of  blood was 
transfused, and a total of  3 L of  normal saline was infused. 
The mean random blood sugar (measured hourly) was 12.5 
mmol/L; 6 mmol/L of  soluble insulin was administered 
once, in addition to the continuous glucose, potassium, 
insulin infusion. The patient remained haemodynamically 
stable and comfortable throughout the procedure.
Postoperatively, the patient was admitted to the intensive care 
unit for observation and pain management, which consisted 
of  continuous infusion of  0.5% lidocaine–adrenaline at 4 
mL/hour, and intravenous paracetamol at 600 mg 8-hourly 
for 48 hours to complement analgesia. The patient resumed 
oral feeding about 6 hours postoperatively. Soluble insulin 
was converted to Mixtard insulin injection  twice daily, oral 
antihypertensive was commenced on the first postoperative 
day. The patient was discharged from the ICU and the hospital 
on the second and sixth postoperative days, respectively.
Discussion
Mastectomy is traditionally performed under general 
anaesthesia. This was the first case of  mastectomy under 
thoracic epidural anaesthesia in our centre. In a previous 
study, Balzarena documented the safety and superiority of  
thoracic epidural over general anaesthesia in 40 patients 
scheduled for mastectomy. In that study, thoracic epidural 
was found to be superior to general anaesthesia in terms of  
haemodynamic stability, reduced nausea and vomiting, lower 
analgesic consumption, superior postoperative analgesia, and 
shorter duration of  hospitalisation.1 Similar observations 
have been reported by other researchers.2,3,4
The infrequent use of  thoracic epidural anaesthesia for 
oncologic breast surgeries in our environment may be 
attributed to fear of  potential complications of  thoracic 
epidural, which include spinal injury, epidural haemetoma and 
abscess, as well as postdural puncture headache. However, 
with experience and due precautions, these complications 
are extremely rare.45 
Moreover, the benefits of  thoracic epidural anaesthesia 
makes it a technique of  choice in high risk patients.1 Previous 
studies have identified history of  hypertension as a risk factor 
for cardiovascular complications during general anaesthesia.6 
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Conclusions
Thoracic epidural anaesthesia and analgesia for mastectomy 
is feasible, and it offers additional benefits in high-risk 
patients.
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Hypertension has also reported to be more common 
intraoperatively in patients undergoing surgeries under GA 
compared to thoracic epidural.1 During general anaesthesia, 
large increases in blood pressure are usually precipitated 
by laryngoscopy and intubation, surgical stimulation, and 
extubation.1 These airway manipulations are usually avoided 
in thoracic epidural anaesthesia and hence our patient was 
haemodynamically stable throughout the procedure.
Surgery in diabetic patients is associated with greater 
perioperative mortality than surgery in nondiabetic subjects.7,8 
This is due in part to higher incidences of  coronary heart 
disease, hypertension, renal insufficiency and hyperglycemia 
among patients with diabetes.8,9 The metabolic response 
to surgery and anaesthesia promotes hyperglycaemia. This 
is due to the increased secretions of  counterregulatory 
hormones (cathecolamines, cortisol, glucagon and growth 
hormone) and excessive release of  inflammatory cytokines.10 
The magnitude of  the counterregulatory response relates to 
the severity of  surgery, as well as the type of  anaesthesia. 
General anaesthesia has been shown to result in higher 
blood glucose concentrations compared to local and epidural 
anaesthesia.8 On the other hand, spinal epidural abscess is a 
rare but potentially life-threatening complication of  spinal or 
epidural anaesthesia. This risk is increased in diabetic patients 
compared to nondiabetics.11,12 However, the risk–benefit 
assessment of  our patient favoured epidural anaesthesia.
Glycaemic control was suboptimal in this patient. This may 
be attributed to the extensive nature of  dissection involved 
in mastectomy. We used 5% dextrose water plus 5 IU of  
insulin and 5 mmol of  potassium. Perhaps the addition of  
10 IU of  insulin would have improved the glycaemic control.
Regional anaesthesia, especially epidural where feasible, has 
been reported to be safer in asthmatic patients compared 
to general anaesthesia.13 Apart from avoiding airway 
manipulations, which may trigger asthmatic attacks, epidural 
anaesthesia improves wheezing and ameliorates status 
asthmaticus.14 Although our patient had an asthmatic attack 
2 days prior to surgery and was treated, she remained stable 
throughout the procedure.
Etta and Edubio,13 previously reported on thoracic epidural 
anaesthesia for laparotomy in an asthmatic patient. Their 
patient developed acute asthmatic attack postoperatively 
in the general ward, and this was attributed to inadequate 
analgesia since pentazocine and paracetamol were used as per 
the surgeon’s order for acute pain management. Our patient 
was admitted to the ICU for continuous epidural analgesia 
using a syringe pump for at least 48 hours postoperatively. 
This enabled the patient to receive the full benefit of  epidural 
analgesia, since syringe pumps and nurses trained in epidural 
analgesia management were not available in the general ward.
